OFI Invest Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Buy
3,330
+323
+11% +$181K 0.02% 234
2026
Q1
$1.62M Buy
3,007
+1,754
+140% +$1.12M 0.02% 208
2025
Q4
$814K Buy
1,253
+761
+155% +$518K 0.01% 235
2025
Q3
$268K Buy
492
+246
+100% +$149K 0.01% 198
2025
Q2
$112K Sell
246
-4,576
-95% -$2.19M ﹤0.01% 209
2025
Q1
$1.87M Buy
4,822
+87
+2% +$37.8K 0.05% 147
2024
Q4
$1.89M Buy
+4,735
New +$2.08M 0.04% 156
2024
Q2
$2.14M Buy
4,714
+4,659
+8,471% +$2.34M 0.06% 134
2024
Q1
$27.5K Sell
55
-5
-8% -$2.73K ﹤0.01% 273
2023
Q4
$30.1K Hold
60
﹤0.01% 197
2023
Q3
$24.8K Buy
+60
New +$29.9K ﹤0.01% 225

Other funds holding IDXX

OFI Invest Asset Management's IDXX Position: Q2 2026 in Review

OFI Invest Asset Management increased its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, buying an estimated $181K and bringing the position to 3,330 shares worth $1.69M. The position accounts for 0.02% of the portfolio, ranked #234.

OFI Invest Asset Management first reported a position in IDXX in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.14M in Q2 2024. 773 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • OFI Invest Asset Management held 3,330 shares of Idexx Laboratories worth $1.69M as of Q2 2026.
  • OFI Invest Asset Management bought 323 Idexx Laboratories shares in Q2 2026, an estimated $181K.
  • Idexx Laboratories made up 0.02% of OFI Invest Asset Management's portfolio in Q2 2026, its #234 holding.
  • OFI Invest Asset Management first reported a position in Idexx Laboratories in Q3 2023 and has held it in 11 quarters since.
  • OFI Invest Asset Management's Idexx Laboratories position peaked at $2.14M in Q2 2024.
  • 773 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.